Home » Topics » Regulatory » Patents

Patents
RSS

Orally active, selective V2 agonists in development at AHP

March 12, 1999

Recordati claims potent and selective 5-HT1A receptor antagonists for urinary disorders

March 12, 1999

Warner-Lambert prepares irreversible tyrosine kinase inhibitors

March 12, 1999

GABA-A alpha5 subunit-selective inverse agonists from Merck useful for Alzheimer's disease

March 12, 1999

Kynurenine 3-monooxygenase inhibitors for neurodegenerative disorders

March 12, 1999

Novel class of GABA-A receptor ligands for cognitive disorders from Merck

March 11, 1999

Protein prenylation inhibitors under study at Pierre Fabre for use in cancer, etc.

March 11, 1999

Inhibitors of metallo-beta-lactamases discovered at SmithKline Beecham

March 11, 1999

Novel neuraminidase inhibitors described by U. of Florida

March 11, 1999

Heterocyclic factor Xa inhibitors disclosed by Zeneca

March 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...